N. Pauly

发表

Reactive Hyperreninemia Is a Major Determinant of Plasma Angiotensin II During ACE Inhibition

V. Mooser, M. Burnier, B. Waeber, 1990, Journal of cardiovascular pharmacology.

Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril.

R. Wilkinson, J. Aldigier, S. Harper, 1993, British journal of clinical pharmacology.

Converting enzyme inhibition: dissociation between antihypertensive and arterial effects.

M. Safar, R. Asmar, B. Darné, 1992, Journal of human hypertension.

Increased respiratory chemosensitivity induced by infusing almitrine intravenously in healthy man.

N. Stanley, J. Galloway, N. Pauly, 1983, Thorax.

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

E. Aliot, A. Camm, L. Køber, 1995, The New England journal of medicine.

Almitrine improves oxygenation when both awake and asleep in patients with hypoxia and carbon dioxide retention caused by chronic bronchitis and emphysema.

C. Shapiro, N. Douglas, D. Flenley, 1985, The American review of respiratory disease.

Efficacy and Tolerance of Trandolapril (0.5–2 mg) Administered for 4 Weeks in Patients with Mild‐to-Moderate Hypertension

N. Pauly, J. D. de Bruijn, B. Orofiamma, 1994 .

Effect of almitrine on nocturnal hypoxaemia in chronic bronchitis and emphysema, and in patients with central sleep apnoea

C. Shapiro, N. Douglas, D. Flenley, 1983 .

International multicentre study of indapamide in the treatment of essential arterial hypertension.

J. Desprat, N. Pauly, J. Passeron, 1981, Postgraduate medical journal.

Effects of almitrine bismesylate on chemosensitivity in patients with chronic airways obstruction.

N. Stanley, N. Pauly, J. A. Pieczora, 1983, European journal of respiratory diseases. Supplement.